Dr. Lofwall completed residency training in Psychiatry and a clinical research fellowship in behavioral pharmacology at Johns Hopkins University.
She has an outpatient office-based opioid addiction treatment practice and is actively engaged in teaching and clinical research, investigating medication diversion and opioid use disorder treatments.
Dr. Lofwall is the immediate past President of the Kentucky Chapter of the American Society of Addiction Medicine and Associate Editor of the American Academy of Addiction Psychiatry newsletter, recipient of several medical student teaching and mentorship awards, and a member of the Kentucky Governor’s State Prescription Drug Monitoring Program Advisory Council.
Associate Professor, Psychiatry and Behavioral Science
Center on Drug and Alcohol Research
University of Kentucky College of Medicine
Conferences and Curricula involving Michelle
There is a lack of understanding of challenges, needs, and treatment of opioid dependence during pregnancy. Health care providers need an improved understanding of the challenges pregnant opioid dependent...
KASPER and UDS/T can be used as therapeutic clinical tools to help monitor for unintended adverse effects of prescribed opioids (and other controlled drugs with known abuse potential and increasing presence in...
Substance use disorders are common medical disorders that all health care providers should be aware of and have basic knowledge and practice competence. Methodone and buprenorphine are important treatment options...